{"schema_version":"secwatch.filing_event.v1","accession":"0001079973-24-001179","form_type":"8-K","ticker":"LCTC","cik":"0001493137","company_name":"Lifeloc Technologies, Inc","filed_at":"2024-08-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.232542+00:00","generated_at":"2026-05-31T10:49:48.251285+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Lifeloc Q2 2024 net loss of $298K; rev $2.387M (+5% YoY); SpinDx beta in 2024","bullets":["Net loss $(298K) ($0.12/diluted) vs net income $55K ($0.02) in Q2 2023.","Revenue increased 5% to $2.387M; gross margin fell to 41.6% from 45.7%.","R&D spending rose 67% to $662K, primarily for SpinDx saliva THC detection.","Cash at $505K; post-quarter closed $750K credit line + $798K private placement.","SpinDx beta testing planned H2 2024; commercial launch targeted for 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001079973-24-001179","json":"https://secwatch.observer/filing/0001079973-24-001179.json","markdown":"https://secwatch.observer/filing/0001079973-24-001179.md","text":"https://secwatch.observer/filing/0001079973-24-001179.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1493137/000107997324001179/0001079973-24-001179-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1493137/000107997324001179/lctc_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T10:49:48.251285+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}